“…One-dimensional (1D) nanomaterials, including nanorods, nanotubes, nanoribbons, nanowires, and nanofibers, have been applied as the drug carrier or synergistic drug materials. [31,32] Due to their unique chemical structures, good biocompatibility, high specific surface area, and other related physicochemical properties, 1D nanomaterials were widely applied to the biological field. [33] In recent years, some research showed that 1D nanomaterials with special structures, such as the radial size seamless carbon tube, can interact with amyloid protein and reduce the aggregation of amyloid protein.…”